Upadacitinib
Upadacitinib was ranked 1712th of 1,796 medicines by items in May 2026, with 1 items, down 50.0% on a year earlier.
Dispensed in May 2026
Rolling 12 months
Net ingredient cost · May 2026
Figure 1. Upadacitinib: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to May 2026
Embed this chart
Free to reuse with the credit line above.
At a glance
- Therapeutic class Drugs used in rheumatic diseases and gout
- Presentations 1 shown
- Average cost / item £2,087.10
- Year on year Down 50.0% on a year earlier
Top presentations, May 2026
The individual products dispensed under Upadacitinib this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Rinvoq 45mg modified-release tablets | 1001030AEBBACAC | 1 | £2,087 |
Source: NHSBSA Prescription Cost Analysis · to May 2026 OGL v3.0
Where Upadacitinib is dispensed
The regions and dispensing practices with the highest Upadacitinib volumes.
Top dispensing practices
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
In NHS hospitals
Upadacitinib is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.
Compare Upadacitinib with
Other medicines in the same BNF section, by prescribing volume.
Download this data
The monthly series for Upadacitinib is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.